Literature DB >> 21681708

Prevalence, risk factors and severity of asthma symptoms in children of Kermanshah, IRAN: ISAAC phase I, II.

Mehdi Zobeiri1.   

Abstract

Asthma is the most common chronic disorder of school-age children and youth, with rising prevalence in all over the world. By attention to the geographic area there is considerable difference in the prevalence of asthma. The International Study of Asthma and Allergies in Childhood (ISAAC), was founded to maximize the value of epidemiological research into asthma and allergic disease by establishing a standardized methodology and facilitating international collaboration. To determine the prevalence of asthma and related symptoms in Kermanshah (a city in west of IRAN) schoolchildren and also identifying the related variables that increased asthma risk using the ISAAC protocols. This descriptive analytic study was done by the ISAAC written questionnaire and additional questions about family number, demographic and socio-economic characteristics of two groups of first and second grade of primary and guidance schools (6-7 y, 13-14 y). Suggested sample size were applied and selected randomly. Results were analyzed by SPSS soft ware by 95% confidence interval. The ISAAC-written questionnaire was completed by a total of 6236 (48.7% were 6-7 and 51/3% were 13-14 years old) schoolchildren. 50.4% of students were girls and 49/6% were boys. The prevalence of diseases and symptoms were as follows: 20.6% had ever wheezing (27.4% in 13-14 years old and 13.4% in 6-7 years old children and it was 21.6% in girls and 19.5% in boys). Among which the estimated mean national 12-month prevalence of wheeze (current wheeze), speech limiting wheeze , exercise wheeze, night cough and physician diagnosed asthma (ever asthma) were respectively 30.1%, 5.4%, 9.4%, 7.3% and 3.3% for the 6-7 year age group and 44.2%, 13.5%, 28.9% , 17.4% and 2.1% for the 13-14 year age group. Current wheeze was higher in Childs and adolescents with family history of smoking and in higher family number. Comparing with regional study the results of this epidemiological survey of asthma in Kermanshah indicate that asthma is more common here, more prevalent in girls than boys and is higher in 13-14 years old than 6-7 years old but sever asthma is much less common. The results may be due to better diagnosis and better control of disease.

Entities:  

Mesh:

Year:  2011        PMID: 21681708

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  6 in total

1.  Speech and language therapy for management of chronic cough.

Authors:  Claire Slinger; Syed B Mehdi; Stephen J Milan; Steven Dodd; Jessica Matthews; Aashish Vyas; Paul A Marsden
Journal:  Cochrane Database Syst Rev       Date:  2019-07-23

Review 2.  Operational definitions of asthma in recent epidemiological studies are inconsistent.

Authors:  Ana Sá-Sousa; Tiago Jacinto; Luís Filipe Azevedo; Mário Morais-Almeida; Carlos Robalo-Cordeiro; António Bugalho-Almeida; Jean Bousquet; João Almeida Fonseca
Journal:  Clin Transl Allergy       Date:  2014-08-04       Impact factor: 5.871

3.  Prevalence of Asthma and Respiratory Symptoms among University Students in Sari (North of Iran).

Authors:  Moslem Mohammadi; Behzad Parsi; Naghi Shahabi Majd
Journal:  Tanaffos       Date:  2016

Review 4.  Prevalence of asthma among Middle Eastern children: A systematic review.

Authors:  Masoud Mirzaei; Mehran Karimi; Shima Beheshti; Masoud Mohammadi
Journal:  Med J Islam Repub Iran       Date:  2016-10-02

5.  A comparison of impulse oscillometry and spirometry values in patients with gastroesophageal reflux disease.

Authors:  Esmaeil Eidani; Seyed Jalal Hashemi; Hanieh Raji; Mehdi Hosaini Askarabadi
Journal:  Middle East J Dig Dis       Date:  2013-01

6.  The Prevalence of Asthma among Iranian Children and Adolescent: A Systematic Review and Meta-Analysis.

Authors:  Neda Rahimian; Mohammad Aghajanpour; Leila Jouybari; Pedram Ataee; Asadollah Fathollahpour; Nasrin Lamuch-Deli; Wesam Kooti; Rasoul Nasiri Kalmarzi
Journal:  Oxid Med Cell Longev       Date:  2021-08-21       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.